Resilience

Resilience is a technology-focused biomanufacturing company dedicated to broadening access to complex medicines. They aim to revolutionize the way medicines are made, funded, and scaled by leveraging advanced technology, a network of high-tech, end-to-end manufacturing solutions, and a commitment to driving down the cost of goods and reducing vein-to-vein time for therapies. This approach has led to a robust network of facilities and partnerships, allowing Resilience to offer comprehensive services across various modalities including biologics, vaccines, gene therapy, cell therapy, and nucleic acids.

Their unique approach involves integrating expertise across five core modalities, deploying nascent technologies, and creating a digitally-connected network of facilities. This allows Resilience to offer a range of solutions, from early-stage incubation to commercial manufacturing, and to support clients throughout the entire drug development process. They are committed to building a more resilient future for medicine, enabling greater access to life-saving therapies for patients around the world.

Resilience offers flexible work arrangements, including opportunities for both virtual and in-person employment. They are actively seeking individuals with diverse backgrounds and skills, and their interview process is adaptable to accommodate candidate preferences and safety measures. This flexibility extends to their employee benefits package, which includes options like subsidized backup care, fertility support, and generous time off policies.

Resilience offers a comprehensive benefits package that includes health care coverage for employees and eligible family members, including domestic partners. The company also provides generous programs such as subsidized in-home and in-center backup care, fertility care support, and flexible time off to support employee well-being and personal needs.

Resilience, a technology-focused biomanufacturing company, aims to revolutionize the development and production of complex medicines, like cell and gene therapies, to broaden access to life-saving treatments and safeguard global health security. They strive to accelerate the journey of novel therapies from initial discovery to commercial manufacturing, empowering researchers and innovators with robust infrastructure, state-of-the-art technologies, and a collaborative approach that prioritizes speed, efficiency, and quality.

Resilience promotes a culture of innovation, collaboration, and high performance, driven by a set of "phenotypes" that emphasize resilience, grit, a builder mentality, quality and rigor, velocity, service orientation, ownership, and a balance of EQ and IQ. This culture encourages employees to be passionate, persistent, resourceful, detail-oriented, adaptable, and service-minded, while fostering a collaborative and inclusive environment that values diverse viewpoints and continuous learning.

Resilience is committed to fostering a diverse and inclusive ecosystem where all employees feel valued, respected, and have a sense of belonging. They believe that a diverse team leads to better business decisions and are committed to creating an equitable environment where everyone can reach their full potential. This commitment extends beyond their workforce to include their suppliers, partners, and customers, reflecting their belief that a diverse and inclusive environment is crucial for positive change and stronger communities.